Your browser doesn't support javascript.
loading
Acemannan increased bone surface, bone volume, and bone density in a calvarial defect model in skeletally-mature rats.
Godoy, Dyna Jeanne D; Chokboribal, Jaroenporn; Pauwels, Ruben; Banlunara, Wijit; Sangvanich, Polkit; Jaroenporn, Sukanya; Thunyakitpisal, Pasutha.
Afiliación
  • Godoy DJD; Dental Biomaterials Science Program, Graduate School, Chulalongkorn University, Bangkok, Thailand.
  • Chokboribal J; Department of Materials Science, Faculty of Science, Chulalongkorn University, Bangkok, Thailand.
  • Pauwels R; Department of Materials Science, Faculty of Science and Technology, Phranakhon Rajabhat University, Bangkok, Thailand.
  • Banlunara W; OMFS-IMPATH Research Group, Department of Imaging & Pathology, Biomedical Sciences Group, KU Leuven, Leuven, Belgium.
  • Sangvanich P; Department of Radiology, Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand.
  • Jaroenporn S; Department of Pathology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand.
  • Thunyakitpisal P; Department of Chemistry, Faculty of Science, Chulalongkorn University, Bangkok, Thailand.
J Dent Sci ; 13(4): 334-341, 2018 Dec.
Article en En | MEDLINE | ID: mdl-30895142
ABSTRACT
BACKGROUND/

PURPOSE:

Acemannan, a ß-(1-4)-acetylated polymannose extracted from Aloe vera gel, has been proposed as biomaterial for bone regeneration. The aim of this study was to investigate the effect of acemannan in calvarial defect healing. MATERIALS AND

METHODS:

Acemannan was processed to freeze-dried sponge form and disinfected by UV irradiation. Thirty-five female Sprague-Dawley rats were used in the in vivo study. Seven-mm diameter mid-calvarial defects were created and randomly allocated into blood clot control (C), acemannan 1 mg (A1), 2 mg (A2), 4 mg (A4), and 8 mg (A8) groups (n = 7). After four weeks, the calvarial specimens were subjected to microcomputed tomography (microCT) and histopathological analysis.

RESULTS:

MicroCT revealed a significant increase in bone surface and bone volume in the A1 and A2 groups, and tissue mineral density in the A4 and A8 groups compared with the control group (p < 0.05). Histologically, the acemannan-treated groups had denser bone matrix compared with the control group.

CONCLUSION:

Acemannan is an effective bioactive agent for bone regeneration, enhancing bone growth as assayed in two- and three-dimensions.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Dent Sci Año: 2018 Tipo del documento: Article País de afiliación: Tailandia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Dent Sci Año: 2018 Tipo del documento: Article País de afiliación: Tailandia